Eli Lilly Corp. buy UBS Group AG
Start price
20.10.23
/
50%
€557.00
Target price
20.10.24
€670.67
Performance (%)
51.40%
End price
21.10.24
€843.30
Summary
This prediction ended on 21.10.24 with a price of €843.30. With a performance of 51.40% the BUY prediction by UBS_Group_AG was a big success. UBS_Group_AG has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €4.63 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | 3.550% | 3.550% | 81.619% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at UBS Group AG. They now have a $710.00 price target on the stock, up previously from $612.00.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Eli Lilly Corp.
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€537.70
08.08.25
08.08.25
€767.46
08.08.26
08.08.26
91.56%
09.08.26
09.08.26
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24